GM Advisory Group’s ResMed RMD Stock Holding History

GM Advisory Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$509K	Hold	2,266	–	–	0.02%	230
2025 Q4	$546K	Hold	2,266	–	–	0.02%	206
2025 Q3	$620K	Hold	2,266	–	–	0.03%	177
2025 Q2	$585K	Hold	2,266	–	–	0.03%	181
2025 Q1	$507K	Hold	2,266	–	–	0.03%	177
2024 Q4	$518K	Hold	2,266	–	–	0.03%	164
2024 Q3	$553K	Hold	2,266	–	–	0.03%	154
2024 Q2	$434K	Hold	2,266	–	–	0.03%	160
2024 Q1	$449K	Hold	2,266	–	–	0.03%	154
2023 Q4	$390K	Hold	2,266	–	–	0.03%	154
2023 Q3	$335K	Hold	2,266	–	–	0.03%	149
2023 Q2	$495K	Hold	2,266	–	–	0.04%	129
2023 Q1	$496K	Hold	2,266	–	–	0.05%	124
2022 Q4	$472K	Hold	2,266	–	–	0.05%	118
2022 Q3	$495K	Hold	2,266	–	–	0.06%	118
2022 Q2	$475K	Sell	2,266 -204	-8%	-$43.4K	0.07%	114
2022 Q1	$599K	Hold	2,470	–	–	0.07%	117
2021 Q4	$643K	Sell	2,470 -175	-7%	-$45.4K	0.06%	118
2021 Q3	$697K	Buy	2,645 +175	+7%	+$47.9K	0.07%	107
2021 Q2	$609K	Hold	2,470	–	–	0.06%	117
2021 Q1	$479K	Hold	2,470	–	–	0.06%	121
2020 Q4	$525K	Hold	2,470	–	–	0.07%	101
2020 Q3	$423K	Hold	2,470	–	–	0.06%	105
2020 Q2	$474K	Buy	+2,470	New	+$404K	0.09%	105

Other funds holding RMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GM Advisory Group's RMD Position: Q1 2026 in Review

GM Advisory Group held its ResMed (RMD) position steady in Q1 2026 at 2,266 shares worth $509K. The position accounts for 0.02% of the portfolio, ranked #230.

GM Advisory Group first reported a position in RMD in Q2 2020 and has held it in 24 quarters since. The position peaked at $697K in Q3 2021. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

GM Advisory Group held 2,266 shares of ResMed worth $509K as of Q1 2026.
GM Advisory Group left its ResMed share count unchanged in Q1 2026.
ResMed made up 0.02% of GM Advisory Group's portfolio in Q1 2026, its #230 holding.
GM Advisory Group first reported a position in ResMed in Q2 2020 and has held it in 24 quarters since.
GM Advisory Group's ResMed position peaked at $697K in Q3 2021.
938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on GM Advisory Group's 13F filing for Q1 2026, filed 28 Apr 2026.